Cardiology journal最新文献

筛选
英文 中文
Baseline left ventricular ejection fraction predicts the magnitude of improvement in patients taking sacubitril/valsartan. 基线左室射血分数预测服用苏比里尔/缬沙坦的患者改善程度。
Cardiology journal Pub Date : 2025-01-01 Epub Date: 2025-05-22 DOI: 10.5603/cj.104310
José-Manuel Rubio-Campal, Carlos Rodriguez Lopez, Carla Lázaro Rivera, Francisco de Asís Díaz Cortegana, Loreto Bravo Calero, Cristina Aguilera Agudo, José María Romero-Otero, José Tuñón Fernández
{"title":"Baseline left ventricular ejection fraction predicts the magnitude of improvement in patients taking sacubitril/valsartan.","authors":"José-Manuel Rubio-Campal, Carlos Rodriguez Lopez, Carla Lázaro Rivera, Francisco de Asís Díaz Cortegana, Loreto Bravo Calero, Cristina Aguilera Agudo, José María Romero-Otero, José Tuñón Fernández","doi":"10.5603/cj.104310","DOIUrl":"10.5603/cj.104310","url":null,"abstract":"<p><strong>Background: </strong>Sacubitril/valsartan (S/V) improve left ventricular ejection fraction (LVEF) in heart failure patients, but the magnitude of improvement may depend on baseline values.</p><p><strong>Methods: </strong>We analyzed whether baseline LVEF can predict its improvement in patients with LVEF ≤ 45% receiving S/V. Patients were divided into 4 groups (G) according to baseline LVEF (G1: ≤ 20%; G2: 21-30%; G3: 31-40%; G4: 41-45%).</p><p><strong>Results: </strong>We included 256 patients (age 73 ± 12 years; 73% male; 174 ischemic cardiomyopathy [CM], 82 nonischemic CM) and assessed LVEF at S/V initiation and at 6 and 12 months of therapy. Baseline LVEF (%) values (overall 30.9 ± 8.6) were: G1: 17.3 ± 3.3; G2: 27.5 ± 2.4; G3: 35.5 ± 2; G4: 44.4 ± 1. LVEF increased in 62% of patients, reaching 34.3 ± 10.4% and 35.5 ± 11.2% at 6 and 12 months, respectively (p < 0.001). A significantly higher absolute LVEF increase was found in Groups 3 (7.2 ± 4.3) and 4 (4.2 ± 3.05) than in Groups 1 (0.6 ± 1.5) and 2 (3.5 ± 1.5), in women (5.9 ± 4.4 vs. 4.1 ± 4.5; p < 0.001), with high S/V doses (7.4 ± 4.7 vs. 4.3 ± 4.4; p < 0.001), and in nonischemic CM (6.3 ± 4.9 vs. 3.8 ± 4.2; p < 0.001). On multivariate analysis, female sex (OR 2.18; 95% CI [1.06-4.48]; p = 0.034), high dose (OR 3.38; 95% CI [1.10-10.34]; p = 0.033), and baseline LVEF > 30% (OR 8.62; 95% CI [4.69-15.82]; p = 0.001) were significant predictors of LVEF improvement.</p><p><strong>Conclusions: </strong>LVEF improvement with S/V depends on baseline values, sex, and dose.</p>","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":"270-277"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12221323/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144121613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paradoxical embolism via patent foramen ovale: a rare cause of myocardial infarction in an air traveler. 经卵圆孔未闭的矛盾栓塞:航空旅客心肌梗死的罕见原因。
Cardiology journal Pub Date : 2025-01-01 DOI: 10.5603/cj.99831
Michał Pałuchowski, Olga Jakubik, Piotr Tyślerowicz, Arkadiusz Pietrasik, Aleksandra Gąsecka
{"title":"Paradoxical embolism via patent foramen ovale: a rare cause of myocardial infarction in an air traveler.","authors":"Michał Pałuchowski, Olga Jakubik, Piotr Tyślerowicz, Arkadiusz Pietrasik, Aleksandra Gąsecka","doi":"10.5603/cj.99831","DOIUrl":"10.5603/cj.99831","url":null,"abstract":"","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":"32 3","pages":"332-333"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12221316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144531689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Galectin-3: Heart failure biomarker in pediatric heart defects. 半乳糖凝集素-3:儿童心脏缺陷的心力衰竭生物标志物。
Cardiology journal Pub Date : 2025-01-01 Epub Date: 2025-02-25 DOI: 10.5603/cj.99070
Daniel Gondko, Patrycja Dębiec, Jakub Roman, Nikodem Pietrzak, Krzysztof Kocot, Jacek Kusa
{"title":"Galectin-3: Heart failure biomarker in pediatric heart defects.","authors":"Daniel Gondko, Patrycja Dębiec, Jakub Roman, Nikodem Pietrzak, Krzysztof Kocot, Jacek Kusa","doi":"10.5603/cj.99070","DOIUrl":"10.5603/cj.99070","url":null,"abstract":"<p><p>Galectin-3 (Gal-3), a β-galactoside-binding lectin, has emerged as a potential diagnostic and prognostic biomarker for various diseases, including certain heart and kidney diseases, as well as cancer. Its significance is particularly notable in the context of congenital heart defects (CHD), which are the most prevalent congenital malformations, occurring in 6 to 8 out of every 1000 live births. Symptoms of heart failure (HF) in patients with congenital heart defects can manifest early in life, but in some cases, the disease progresses gradually, leading to a gradual decline in quality of life and the development of various complications. This variability underscores the need for early biomarkers to detect HF development in pediatric patients. Gal-3 plays a key role in myocardial remodeling, making it a promising candidate for advancing the diagnosis and management of HF in CHD patients. It is especially relevant in pediatric care, where early detection and intervention can significantly alter disease progression and patient outcomes. This review aims to consolidate current knowledge on the utility of Gal-3 in predicting HF among pediatric patients with CHD, highlighting its potential in changing the direction of diagnosis and treatment in this vulnerable patient population.</p>","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":"175-188"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12068239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143495048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EASY OR NOT. European-Asian Six countries Yearly consensus On Recent guidelines: arterial hypertension, atrial fibrillation, chronic coronary syndromes, and peripheral artery diseases. Novel Or conventional Treatment options for these patients. Position Paper 2024. 不管容易不容易。欧洲-亚洲6国近期指南年度共识:动脉高血压、心房颤动、慢性冠状动脉综合征和外周动脉疾病。这些患者的新型或传统治疗方案。立场文件2024
Cardiology journal Pub Date : 2025-01-01 Epub Date: 2025-05-13 DOI: 10.5603/cj.105140
Krzysztof J Filipiak, Matteo Cameli, Santiago J Freire, Rahima Gabulova, Gulnoz Khamidullaeva, Anna Tomaszuk-Kazberuk, Agnieszka Kuzior, Francisco Javier Martinez-Martin, Ulvi Mirzoyev, Ulugbek Nizamov, Nguyen Van Tan, Aleksandra Gąsecka
{"title":"EASY OR NOT. European-Asian Six countries Yearly consensus On Recent guidelines: arterial hypertension, atrial fibrillation, chronic coronary syndromes, and peripheral artery diseases. Novel Or conventional Treatment options for these patients. Position Paper 2024.","authors":"Krzysztof J Filipiak, Matteo Cameli, Santiago J Freire, Rahima Gabulova, Gulnoz Khamidullaeva, Anna Tomaszuk-Kazberuk, Agnieszka Kuzior, Francisco Javier Martinez-Martin, Ulvi Mirzoyev, Ulugbek Nizamov, Nguyen Van Tan, Aleksandra Gąsecka","doi":"10.5603/cj.105140","DOIUrl":"10.5603/cj.105140","url":null,"abstract":"<p><p>The 2024 guidelines of the European Society of Cardiology (ESC) refer to four very important therapeutic areas: arterial hypertension, atrial fibrillation, chronic coronary syndromes and peripheral artery disease. The ESC countries and their institutional members share a common goal of reducing the burden of cardiovascular diseases, which remain the leading cause of death worldwide. Experts from these six countries - three from Europe and three from Asia - gathered at the annual meeting to briefly present the epidemiological situation regarding selected issues addressed in the 2024 ESC guidelines, and to create a document highlighting the significant progress in pharmacotherapy. The new guidelines allow us to identify particularly important therapeutic areas and unmet pharmaceutical needs within the four treatment guidelines developed by the ESC in 2024. While discussing each of these four documents, 10 subjectively selected points were chosen to highlight what should be kept in mind in daily clinical practice. Altogether, a range of all-risk categories are represented, and the observations made in this position paper are of a universal nature.</p>","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":"213-227"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12221317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143994175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late-onset pericarditis after autologous myoblast cell-sheet transplantation for ischemic cardiomyopathy. 自体成肌细胞片移植治疗缺血性心肌病后迟发性心包炎。
Cardiology journal Pub Date : 2025-01-01 DOI: 10.5603/cj.103492
Ryotaro Matsuo, Tadao Aikawa, Hanako Inoue, Takao Kato, Tohru Minamino
{"title":"Late-onset pericarditis after autologous myoblast cell-sheet transplantation for ischemic cardiomyopathy.","authors":"Ryotaro Matsuo, Tadao Aikawa, Hanako Inoue, Takao Kato, Tohru Minamino","doi":"10.5603/cj.103492","DOIUrl":"10.5603/cj.103492","url":null,"abstract":"","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":"32 3","pages":"342-343"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12221314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144531688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of dyslipidemia in Poland - common diagnostics, early combined therapy. Expert position statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. 5th Declaration of Sopot. 波兰血脂异常的治疗-常见诊断,早期联合治疗。波兰心脏病学会心血管药物治疗工作组认可的专家立场声明。索波特第五次宣言。
Cardiology journal Pub Date : 2025-01-01 Epub Date: 2025-03-31 DOI: 10.5603/cj.103680
Marcin Wełnicki, Iwona Gorczyca-Głowacka, Agnieszka Kapłon-Cieślicka, Maciej Janiszewski, Jarosław D Kasprzak, Przemysław Leszek, Anna Tomaszuk-Kazberuk, Maria Łukasiewicz, Mariusz Tomaniak, Stanisław Surma, Agnieszka Mickiewicz, Krzysztof Narkiewicz, Miłosz Jaguszewski, Zbigniew Krasiński, Daniel Śliż, Artur Mamcarz, Filip M Szymański, Marcin Barylski, Beata Wożakowska-Kapłon, Krzysztof J Filipiak
{"title":"Treatment of dyslipidemia in Poland - common diagnostics, early combined therapy. Expert position statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. 5th Declaration of Sopot.","authors":"Marcin Wełnicki, Iwona Gorczyca-Głowacka, Agnieszka Kapłon-Cieślicka, Maciej Janiszewski, Jarosław D Kasprzak, Przemysław Leszek, Anna Tomaszuk-Kazberuk, Maria Łukasiewicz, Mariusz Tomaniak, Stanisław Surma, Agnieszka Mickiewicz, Krzysztof Narkiewicz, Miłosz Jaguszewski, Zbigniew Krasiński, Daniel Śliż, Artur Mamcarz, Filip M Szymański, Marcin Barylski, Beata Wożakowska-Kapłon, Krzysztof J Filipiak","doi":"10.5603/cj.103680","DOIUrl":"10.5603/cj.103680","url":null,"abstract":"","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":"107-119"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12068240/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of endomyocardial biopsy for surveillance of cardiac allograft rejection: time to move on? 心内膜心肌活检监测同种异体心脏移植排斥反应的作用:是时候继续前进了?
Cardiology journal Pub Date : 2025-01-01 Epub Date: 2025-03-10 DOI: 10.5603/cj.99019
Roberto Gómez-Sánchez, Carlos Ortiz-Bautista, Javier Castrodeza, Zorba Blázquez-Bermejo, Eduardo Zataraín-Nicolás, Adolfo Villa, Ricardo Sanz-Ruiz, Jaime Elízaga, Javier Bermejo
{"title":"The role of endomyocardial biopsy for surveillance of cardiac allograft rejection: time to move on?","authors":"Roberto Gómez-Sánchez, Carlos Ortiz-Bautista, Javier Castrodeza, Zorba Blázquez-Bermejo, Eduardo Zataraín-Nicolás, Adolfo Villa, Ricardo Sanz-Ruiz, Jaime Elízaga, Javier Bermejo","doi":"10.5603/cj.99019","DOIUrl":"10.5603/cj.99019","url":null,"abstract":"","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":"203-205"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12068229/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143588840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rationale and design of the MICE study: Exploration of the temporal relation between electrical and mechanical events during myocardial ischemia. 小鼠研究的基本原理和设计:探索心肌缺血时电和机械事件的时间关系。
Cardiology journal Pub Date : 2025-01-01 Epub Date: 2024-12-03 DOI: 10.5603/cj.98481
Niya Mileva, Teodora Yaneva-Sirakova, Irina Hristova, Despina Georgieva, Greta Koleva, Dimitra Psalla, Ranko Georgiev, Dobrin Vassilev
{"title":"Rationale and design of the MICE study: Exploration of the temporal relation between electrical and mechanical events during myocardial ischemia.","authors":"Niya Mileva, Teodora Yaneva-Sirakova, Irina Hristova, Despina Georgieva, Greta Koleva, Dimitra Psalla, Ranko Georgiev, Dobrin Vassilev","doi":"10.5603/cj.98481","DOIUrl":"10.5603/cj.98481","url":null,"abstract":"","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":"90-97"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11870004/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IVUS-guided cap puncture of a stumpless chronic total occlusion with sliptream technique. 静脉注射引导下滑流技术治疗无残根慢性全闭塞的帽穿刺。
Cardiology journal Pub Date : 2025-01-01 DOI: 10.5603/cj.99193
Mohsen Mohandes, Cristina Moreno, Luis Mauricio Torres, Humberto Coimbra, José Luis Ferreiro
{"title":"IVUS-guided cap puncture of a stumpless chronic total occlusion with sliptream technique.","authors":"Mohsen Mohandes, Cristina Moreno, Luis Mauricio Torres, Humberto Coimbra, José Luis Ferreiro","doi":"10.5603/cj.99193","DOIUrl":"10.5603/cj.99193","url":null,"abstract":"","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":"32 1","pages":"104-105"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11870012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143517680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of the COAPT risk score in Polish patients undergoing transcatheter edge-to-edge repair of severe, functional mitral regurgitation: a multicenter, observational study. 波兰接受经导管边缘到边缘修复严重功能性二尖瓣反流患者COAPT风险评分的验证:一项多中心观察性研究
Cardiology journal Pub Date : 2025-01-01 DOI: 10.5603/cj.100877
Karolina Jasińska-Gniadzik, Michał Łomiak, Jerzy Pręgowski, Zbigniew Chmielak, Piotr Kasprzyk, Jan Kasprzyk, Rafał Gałąska, Michał Chmielecki, Miłosz J Jaguszewski, Marcin Fijałkowski, Aleksandra Topolska, Michał Sekuła, Marcin Grabowski, Janusz Kochman, Adam Rdzanek, Piotr Scislo, Agnieszka Kapłon-Cieślicka, Renata Główczyńska, Monika Budnik, Radosław Piątkowski, Łukasz Kołtowski, Arkadiusz Pietrasik, Aleksandra Gąsecka
{"title":"Validation of the COAPT risk score in Polish patients undergoing transcatheter edge-to-edge repair of severe, functional mitral regurgitation: a multicenter, observational study.","authors":"Karolina Jasińska-Gniadzik, Michał Łomiak, Jerzy Pręgowski, Zbigniew Chmielak, Piotr Kasprzyk, Jan Kasprzyk, Rafał Gałąska, Michał Chmielecki, Miłosz J Jaguszewski, Marcin Fijałkowski, Aleksandra Topolska, Michał Sekuła, Marcin Grabowski, Janusz Kochman, Adam Rdzanek, Piotr Scislo, Agnieszka Kapłon-Cieślicka, Renata Główczyńska, Monika Budnik, Radosław Piątkowski, Łukasz Kołtowski, Arkadiusz Pietrasik, Aleksandra Gąsecka","doi":"10.5603/cj.100877","DOIUrl":"10.5603/cj.100877","url":null,"abstract":"<p><strong>Background: </strong>The COAPT risk score, developed based on the COAPT trial, is a tool to predict the risk of death or hospitalization for heart failure (HFH) within two years after transcatheter edge-to-edge repair (TEER) of mitral regurgitation using a MitraClip device. We aimed to validate the Score in a Polish population.</p><p><strong>Methods: </strong>Patients with severe mitral regurgitation who underwent TEER with MitraClip at three cardiology centers in Poland between November 2015 and February 2023 were included. Patients were divided into two groups based on the COAPT trail criteria: COAPT eligible and COAPT non-eligible. Clinical data were collected from medical records and the COAPT risk score was calculated for each patient. Outcomes were collected during the two-year follow-up period. The primary endpoint was a composite of all-cause mortality and HFH at two-year follow-up and evaluated in the overall cohort and separately for COAPT-eligible and -non-eligible patients.</p><p><strong>Results: </strong>A total of 225 patients were included in the study: 134 COAPT eligible (60%) and 91 COAPT non-eligible (40%). Higher COAPT risk score was associated with increased risk of primary endpoint in the overall population and in COAPT-eligible patients. The score demonstrated moderate discrimination (area under curve [AUC] = 0.581) and poor calibration (Hosmer-Lemeshow [HL] p = 0.085) in the overall population, whereas it showed moderate discrimination (AUC = 0.600) and good calibration (HL p = 0.308) in COAPT-eligible patients.</p><p><strong>Conclusions: </strong>In Polish patients fulfilling COAPT criteria, the COAPT risk score has moderate predictive value for post-procedural outcomes. In COAPT non-eligible patients, novel tools are required to predict outcomes.</p>","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":"32 3","pages":"258-269"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12221333/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144531693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信